Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort

•Children may present with imaging findings of demyelination.•In our cohort, ⅓ had a clinical attack and ¾ developed new MRI activity.•Predictors for disease activity may include sex and juxtacortical lesion count.•T1 hypointense and infratentorial lesions may predict delayed progression.•Current MS...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple sclerosis and related disorders 2023-03, Vol.71, p.104573-104573, Article 104573
Hauptverfasser: Bhise, Vikram, Waltz, Michael, Casper, T. Charles, Aaen, Gregory, Benson, Leslie, Chitnis, Tanuja, Gorman, Mark, Goyal, Manu S., Wheeler, Yolanda, Lotze, Timothy, Mar, Soe, Rensel, Mary, Abrams, Aaron, Rodriguez, Moses, Rose, John, Schreiner, Teri, Shukla, Nikita, Waubant, Emmanuelle, Weinstock-Guttman, Bianca, Ness, Jayne, Krupp, Lauren, Mendelt-Tillema, Jan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 104573
container_issue
container_start_page 104573
container_title Multiple sclerosis and related disorders
container_volume 71
creator Bhise, Vikram
Waltz, Michael
Casper, T. Charles
Aaen, Gregory
Benson, Leslie
Chitnis, Tanuja
Gorman, Mark
Goyal, Manu S.
Wheeler, Yolanda
Lotze, Timothy
Mar, Soe
Rensel, Mary
Abrams, Aaron
Rodriguez, Moses
Rose, John
Schreiner, Teri
Shukla, Nikita
Waubant, Emmanuelle
Weinstock-Guttman, Bianca
Ness, Jayne
Krupp, Lauren
Mendelt-Tillema, Jan
description •Children may present with imaging findings of demyelination.•In our cohort, ⅓ had a clinical attack and ¾ developed new MRI activity.•Predictors for disease activity may include sex and juxtacortical lesion count.•T1 hypointense and infratentorial lesions may predict delayed progression.•Current MS and RIS diagnostic criteria may not be sufficient predictive tools. Limited data is available on children with evidence of silent central nervous system demyelination on MRI. We sought to characterize the population in a US cohort and identify predictors of clinical and radiologic outcomes. We identified 56 patients such patients who presented with incidental MRI findings suspect for demyelination, enrolled through our US Network of Pediatric Multiple Sclerosis Centers, and conducted a retrospective review of 38 patients with MR images, and examined risk factors for development of first clinical event or new MRI activity. MRI were rated based on published MS and radiologically isolated syndrome (RIS) imaging diagnostic criteria. One-third had a clinical attack and ¾ developed new MRI activity over a mean follow-up time of 3.7 years. Individuals in our cohort shared similar demographics to those with clinically definite pediatric-onset MS. We show that sex, presence of infratentorial lesions, T1 hypointense lesions, juxtacortical lesion count, and callosal lesions were predictors of disease progression. Interestingly, the presence of T1 hypointense and infratentorial lesions typically associated with worse outcomes were instead predictive of delayed disease progression on imaging in subgroup analysis. Additionally, currently utilized diagnostic criteria (both McDonald 2017 and RIS criteria) did not provide statistically significant benefit in risk stratification. Our findings underscore the need for further study to determine if criteria currently used for pediatric patients with purely radiographic evidence of demyelination are sufficient.
doi_str_mv 10.1016/j.msard.2023.104573
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2783788433</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2211034823000779</els_id><sourcerecordid>2783788433</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-c3ac0f70b9481fc257337285b73d01f0ad37f8d99b2753c6c1f1781c6776365c3</originalsourceid><addsrcrecordid>eNp9kMlOwzAQhi0EolXpEyChHLm0eElsB4kDqsoiVeJQerYcL-AqiYOdIvr2uHQ5MgePNfP_Hs8HwDWCUwQRvVtPmyiDnmKISarkBSNnYIgxQhNICnp-uud8AMYxrmEKWqCcokswIJQzRBgeguXS1abtM-ta7dqPeJ_Nf2TjWtk732beZjJum673TSqoTJtma-pj17WZzDqjnexDaq6WmfKfPvRX4MLKOprxIY_A6mn-PnuZLN6eX2ePi4kiRdmnUypoGazKnCOrcFohfYkXFSMaIgulJsxyXZYVZgVRVCGLGEeKMkYJLRQZgdv9u13wXxsTe9G4qExdy9b4TRSYccI4zwlJUrKXquBjDMaKLrhGhq1AUOyAirX4Ayp2QMUeaHLdHAZsqsbok-eILwke9gKT1vx2JoionGlVYhKM6oX27t8Bv-KRhtw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2783788433</pqid></control><display><type>article</type><title>Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Bhise, Vikram ; Waltz, Michael ; Casper, T. Charles ; Aaen, Gregory ; Benson, Leslie ; Chitnis, Tanuja ; Gorman, Mark ; Goyal, Manu S. ; Wheeler, Yolanda ; Lotze, Timothy ; Mar, Soe ; Rensel, Mary ; Abrams, Aaron ; Rodriguez, Moses ; Rose, John ; Schreiner, Teri ; Shukla, Nikita ; Waubant, Emmanuelle ; Weinstock-Guttman, Bianca ; Ness, Jayne ; Krupp, Lauren ; Mendelt-Tillema, Jan</creator><creatorcontrib>Bhise, Vikram ; Waltz, Michael ; Casper, T. Charles ; Aaen, Gregory ; Benson, Leslie ; Chitnis, Tanuja ; Gorman, Mark ; Goyal, Manu S. ; Wheeler, Yolanda ; Lotze, Timothy ; Mar, Soe ; Rensel, Mary ; Abrams, Aaron ; Rodriguez, Moses ; Rose, John ; Schreiner, Teri ; Shukla, Nikita ; Waubant, Emmanuelle ; Weinstock-Guttman, Bianca ; Ness, Jayne ; Krupp, Lauren ; Mendelt-Tillema, Jan ; U.S. Network of Pediatric Multiple Sclerosis Centers</creatorcontrib><description>•Children may present with imaging findings of demyelination.•In our cohort, ⅓ had a clinical attack and ¾ developed new MRI activity.•Predictors for disease activity may include sex and juxtacortical lesion count.•T1 hypointense and infratentorial lesions may predict delayed progression.•Current MS and RIS diagnostic criteria may not be sufficient predictive tools. Limited data is available on children with evidence of silent central nervous system demyelination on MRI. We sought to characterize the population in a US cohort and identify predictors of clinical and radiologic outcomes. We identified 56 patients such patients who presented with incidental MRI findings suspect for demyelination, enrolled through our US Network of Pediatric Multiple Sclerosis Centers, and conducted a retrospective review of 38 patients with MR images, and examined risk factors for development of first clinical event or new MRI activity. MRI were rated based on published MS and radiologically isolated syndrome (RIS) imaging diagnostic criteria. One-third had a clinical attack and ¾ developed new MRI activity over a mean follow-up time of 3.7 years. Individuals in our cohort shared similar demographics to those with clinically definite pediatric-onset MS. We show that sex, presence of infratentorial lesions, T1 hypointense lesions, juxtacortical lesion count, and callosal lesions were predictors of disease progression. Interestingly, the presence of T1 hypointense and infratentorial lesions typically associated with worse outcomes were instead predictive of delayed disease progression on imaging in subgroup analysis. Additionally, currently utilized diagnostic criteria (both McDonald 2017 and RIS criteria) did not provide statistically significant benefit in risk stratification. Our findings underscore the need for further study to determine if criteria currently used for pediatric patients with purely radiographic evidence of demyelination are sufficient.</description><identifier>ISSN: 2211-0348</identifier><identifier>EISSN: 2211-0356</identifier><identifier>DOI: 10.1016/j.msard.2023.104573</identifier><identifier>PMID: 36871372</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Autoimmune Diseases of the Nervous System ; Child ; Demyelinating Diseases - diagnostic imaging ; Demyelinating Diseases - epidemiology ; Demyelination ; Disease Progression ; Humans ; Magnetic Resonance Imaging ; MRI ; Multiple Sclerosis - diagnostic imaging ; Multiple Sclerosis - epidemiology ; Pediatric multiple sclerosis ; Radiologically isolated syndrome ; Retrospective Studies ; Risk factors</subject><ispartof>Multiple sclerosis and related disorders, 2023-03, Vol.71, p.104573-104573, Article 104573</ispartof><rights>2023 Elsevier B.V.</rights><rights>Copyright © 2023 Elsevier B.V. All rights reserved.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-c3ac0f70b9481fc257337285b73d01f0ad37f8d99b2753c6c1f1781c6776365c3</citedby><cites>FETCH-LOGICAL-c359t-c3ac0f70b9481fc257337285b73d01f0ad37f8d99b2753c6c1f1781c6776365c3</cites><orcidid>0000-0003-3304-5523</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36871372$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhise, Vikram</creatorcontrib><creatorcontrib>Waltz, Michael</creatorcontrib><creatorcontrib>Casper, T. Charles</creatorcontrib><creatorcontrib>Aaen, Gregory</creatorcontrib><creatorcontrib>Benson, Leslie</creatorcontrib><creatorcontrib>Chitnis, Tanuja</creatorcontrib><creatorcontrib>Gorman, Mark</creatorcontrib><creatorcontrib>Goyal, Manu S.</creatorcontrib><creatorcontrib>Wheeler, Yolanda</creatorcontrib><creatorcontrib>Lotze, Timothy</creatorcontrib><creatorcontrib>Mar, Soe</creatorcontrib><creatorcontrib>Rensel, Mary</creatorcontrib><creatorcontrib>Abrams, Aaron</creatorcontrib><creatorcontrib>Rodriguez, Moses</creatorcontrib><creatorcontrib>Rose, John</creatorcontrib><creatorcontrib>Schreiner, Teri</creatorcontrib><creatorcontrib>Shukla, Nikita</creatorcontrib><creatorcontrib>Waubant, Emmanuelle</creatorcontrib><creatorcontrib>Weinstock-Guttman, Bianca</creatorcontrib><creatorcontrib>Ness, Jayne</creatorcontrib><creatorcontrib>Krupp, Lauren</creatorcontrib><creatorcontrib>Mendelt-Tillema, Jan</creatorcontrib><creatorcontrib>U.S. Network of Pediatric Multiple Sclerosis Centers</creatorcontrib><title>Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort</title><title>Multiple sclerosis and related disorders</title><addtitle>Mult Scler Relat Disord</addtitle><description>•Children may present with imaging findings of demyelination.•In our cohort, ⅓ had a clinical attack and ¾ developed new MRI activity.•Predictors for disease activity may include sex and juxtacortical lesion count.•T1 hypointense and infratentorial lesions may predict delayed progression.•Current MS and RIS diagnostic criteria may not be sufficient predictive tools. Limited data is available on children with evidence of silent central nervous system demyelination on MRI. We sought to characterize the population in a US cohort and identify predictors of clinical and radiologic outcomes. We identified 56 patients such patients who presented with incidental MRI findings suspect for demyelination, enrolled through our US Network of Pediatric Multiple Sclerosis Centers, and conducted a retrospective review of 38 patients with MR images, and examined risk factors for development of first clinical event or new MRI activity. MRI were rated based on published MS and radiologically isolated syndrome (RIS) imaging diagnostic criteria. One-third had a clinical attack and ¾ developed new MRI activity over a mean follow-up time of 3.7 years. Individuals in our cohort shared similar demographics to those with clinically definite pediatric-onset MS. We show that sex, presence of infratentorial lesions, T1 hypointense lesions, juxtacortical lesion count, and callosal lesions were predictors of disease progression. Interestingly, the presence of T1 hypointense and infratentorial lesions typically associated with worse outcomes were instead predictive of delayed disease progression on imaging in subgroup analysis. Additionally, currently utilized diagnostic criteria (both McDonald 2017 and RIS criteria) did not provide statistically significant benefit in risk stratification. Our findings underscore the need for further study to determine if criteria currently used for pediatric patients with purely radiographic evidence of demyelination are sufficient.</description><subject>Autoimmune Diseases of the Nervous System</subject><subject>Child</subject><subject>Demyelinating Diseases - diagnostic imaging</subject><subject>Demyelinating Diseases - epidemiology</subject><subject>Demyelination</subject><subject>Disease Progression</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>MRI</subject><subject>Multiple Sclerosis - diagnostic imaging</subject><subject>Multiple Sclerosis - epidemiology</subject><subject>Pediatric multiple sclerosis</subject><subject>Radiologically isolated syndrome</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><issn>2211-0348</issn><issn>2211-0356</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMlOwzAQhi0EolXpEyChHLm0eElsB4kDqsoiVeJQerYcL-AqiYOdIvr2uHQ5MgePNfP_Hs8HwDWCUwQRvVtPmyiDnmKISarkBSNnYIgxQhNICnp-uud8AMYxrmEKWqCcokswIJQzRBgeguXS1abtM-ta7dqPeJ_Nf2TjWtk732beZjJum673TSqoTJtma-pj17WZzDqjnexDaq6WmfKfPvRX4MLKOprxIY_A6mn-PnuZLN6eX2ePi4kiRdmnUypoGazKnCOrcFohfYkXFSMaIgulJsxyXZYVZgVRVCGLGEeKMkYJLRQZgdv9u13wXxsTe9G4qExdy9b4TRSYccI4zwlJUrKXquBjDMaKLrhGhq1AUOyAirX4Ayp2QMUeaHLdHAZsqsbok-eILwke9gKT1vx2JoionGlVYhKM6oX27t8Bv-KRhtw</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Bhise, Vikram</creator><creator>Waltz, Michael</creator><creator>Casper, T. Charles</creator><creator>Aaen, Gregory</creator><creator>Benson, Leslie</creator><creator>Chitnis, Tanuja</creator><creator>Gorman, Mark</creator><creator>Goyal, Manu S.</creator><creator>Wheeler, Yolanda</creator><creator>Lotze, Timothy</creator><creator>Mar, Soe</creator><creator>Rensel, Mary</creator><creator>Abrams, Aaron</creator><creator>Rodriguez, Moses</creator><creator>Rose, John</creator><creator>Schreiner, Teri</creator><creator>Shukla, Nikita</creator><creator>Waubant, Emmanuelle</creator><creator>Weinstock-Guttman, Bianca</creator><creator>Ness, Jayne</creator><creator>Krupp, Lauren</creator><creator>Mendelt-Tillema, Jan</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3304-5523</orcidid></search><sort><creationdate>202303</creationdate><title>Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort</title><author>Bhise, Vikram ; Waltz, Michael ; Casper, T. Charles ; Aaen, Gregory ; Benson, Leslie ; Chitnis, Tanuja ; Gorman, Mark ; Goyal, Manu S. ; Wheeler, Yolanda ; Lotze, Timothy ; Mar, Soe ; Rensel, Mary ; Abrams, Aaron ; Rodriguez, Moses ; Rose, John ; Schreiner, Teri ; Shukla, Nikita ; Waubant, Emmanuelle ; Weinstock-Guttman, Bianca ; Ness, Jayne ; Krupp, Lauren ; Mendelt-Tillema, Jan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-c3ac0f70b9481fc257337285b73d01f0ad37f8d99b2753c6c1f1781c6776365c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Autoimmune Diseases of the Nervous System</topic><topic>Child</topic><topic>Demyelinating Diseases - diagnostic imaging</topic><topic>Demyelinating Diseases - epidemiology</topic><topic>Demyelination</topic><topic>Disease Progression</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>MRI</topic><topic>Multiple Sclerosis - diagnostic imaging</topic><topic>Multiple Sclerosis - epidemiology</topic><topic>Pediatric multiple sclerosis</topic><topic>Radiologically isolated syndrome</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><toplevel>online_resources</toplevel><creatorcontrib>Bhise, Vikram</creatorcontrib><creatorcontrib>Waltz, Michael</creatorcontrib><creatorcontrib>Casper, T. Charles</creatorcontrib><creatorcontrib>Aaen, Gregory</creatorcontrib><creatorcontrib>Benson, Leslie</creatorcontrib><creatorcontrib>Chitnis, Tanuja</creatorcontrib><creatorcontrib>Gorman, Mark</creatorcontrib><creatorcontrib>Goyal, Manu S.</creatorcontrib><creatorcontrib>Wheeler, Yolanda</creatorcontrib><creatorcontrib>Lotze, Timothy</creatorcontrib><creatorcontrib>Mar, Soe</creatorcontrib><creatorcontrib>Rensel, Mary</creatorcontrib><creatorcontrib>Abrams, Aaron</creatorcontrib><creatorcontrib>Rodriguez, Moses</creatorcontrib><creatorcontrib>Rose, John</creatorcontrib><creatorcontrib>Schreiner, Teri</creatorcontrib><creatorcontrib>Shukla, Nikita</creatorcontrib><creatorcontrib>Waubant, Emmanuelle</creatorcontrib><creatorcontrib>Weinstock-Guttman, Bianca</creatorcontrib><creatorcontrib>Ness, Jayne</creatorcontrib><creatorcontrib>Krupp, Lauren</creatorcontrib><creatorcontrib>Mendelt-Tillema, Jan</creatorcontrib><creatorcontrib>U.S. Network of Pediatric Multiple Sclerosis Centers</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Multiple sclerosis and related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhise, Vikram</au><au>Waltz, Michael</au><au>Casper, T. Charles</au><au>Aaen, Gregory</au><au>Benson, Leslie</au><au>Chitnis, Tanuja</au><au>Gorman, Mark</au><au>Goyal, Manu S.</au><au>Wheeler, Yolanda</au><au>Lotze, Timothy</au><au>Mar, Soe</au><au>Rensel, Mary</au><au>Abrams, Aaron</au><au>Rodriguez, Moses</au><au>Rose, John</au><au>Schreiner, Teri</au><au>Shukla, Nikita</au><au>Waubant, Emmanuelle</au><au>Weinstock-Guttman, Bianca</au><au>Ness, Jayne</au><au>Krupp, Lauren</au><au>Mendelt-Tillema, Jan</au><aucorp>U.S. Network of Pediatric Multiple Sclerosis Centers</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort</atitle><jtitle>Multiple sclerosis and related disorders</jtitle><addtitle>Mult Scler Relat Disord</addtitle><date>2023-03</date><risdate>2023</risdate><volume>71</volume><spage>104573</spage><epage>104573</epage><pages>104573-104573</pages><artnum>104573</artnum><issn>2211-0348</issn><eissn>2211-0356</eissn><abstract>•Children may present with imaging findings of demyelination.•In our cohort, ⅓ had a clinical attack and ¾ developed new MRI activity.•Predictors for disease activity may include sex and juxtacortical lesion count.•T1 hypointense and infratentorial lesions may predict delayed progression.•Current MS and RIS diagnostic criteria may not be sufficient predictive tools. Limited data is available on children with evidence of silent central nervous system demyelination on MRI. We sought to characterize the population in a US cohort and identify predictors of clinical and radiologic outcomes. We identified 56 patients such patients who presented with incidental MRI findings suspect for demyelination, enrolled through our US Network of Pediatric Multiple Sclerosis Centers, and conducted a retrospective review of 38 patients with MR images, and examined risk factors for development of first clinical event or new MRI activity. MRI were rated based on published MS and radiologically isolated syndrome (RIS) imaging diagnostic criteria. One-third had a clinical attack and ¾ developed new MRI activity over a mean follow-up time of 3.7 years. Individuals in our cohort shared similar demographics to those with clinically definite pediatric-onset MS. We show that sex, presence of infratentorial lesions, T1 hypointense lesions, juxtacortical lesion count, and callosal lesions were predictors of disease progression. Interestingly, the presence of T1 hypointense and infratentorial lesions typically associated with worse outcomes were instead predictive of delayed disease progression on imaging in subgroup analysis. Additionally, currently utilized diagnostic criteria (both McDonald 2017 and RIS criteria) did not provide statistically significant benefit in risk stratification. Our findings underscore the need for further study to determine if criteria currently used for pediatric patients with purely radiographic evidence of demyelination are sufficient.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>36871372</pmid><doi>10.1016/j.msard.2023.104573</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-3304-5523</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2211-0348
ispartof Multiple sclerosis and related disorders, 2023-03, Vol.71, p.104573-104573, Article 104573
issn 2211-0348
2211-0356
language eng
recordid cdi_proquest_miscellaneous_2783788433
source MEDLINE; Alma/SFX Local Collection
subjects Autoimmune Diseases of the Nervous System
Child
Demyelinating Diseases - diagnostic imaging
Demyelinating Diseases - epidemiology
Demyelination
Disease Progression
Humans
Magnetic Resonance Imaging
MRI
Multiple Sclerosis - diagnostic imaging
Multiple Sclerosis - epidemiology
Pediatric multiple sclerosis
Radiologically isolated syndrome
Retrospective Studies
Risk factors
title Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T19%3A44%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Silent%20findings:%20Examination%20of%20asymptomatic%20demyelination%20in%20a%20pediatric%20US%20cohort&rft.jtitle=Multiple%20sclerosis%20and%20related%20disorders&rft.au=Bhise,%20Vikram&rft.aucorp=U.S.%20Network%20of%20Pediatric%20Multiple%20Sclerosis%20Centers&rft.date=2023-03&rft.volume=71&rft.spage=104573&rft.epage=104573&rft.pages=104573-104573&rft.artnum=104573&rft.issn=2211-0348&rft.eissn=2211-0356&rft_id=info:doi/10.1016/j.msard.2023.104573&rft_dat=%3Cproquest_cross%3E2783788433%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2783788433&rft_id=info:pmid/36871372&rft_els_id=S2211034823000779&rfr_iscdi=true